References
- Ward K, Pattabiraman N. Comparative anatomy of phospholipase A2 structures. Adv Exp Med Biol 1990; 279: 23–36
- Glaser K B, Mobilio D, Chang J Y, Senko N. Phospholipase A2 enzymes: regulation and inhibition. Trends Pharmacol Sci 1993; 14: 92–8
- Kramer R M, Hession C, Johansen B. Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem 1989; 264: 5768–75
- Abita J-P, Lazdunski M, Bonsen PPM, Pieterson W A, De Haas G H. Zymogen-enzyme transformations: on the mechanism of activation of prophospholipase A2. Eur J Biochem 1972; 30: 37–47
- Dufton M J, Hider R C. Classification of phospholipases A2 according to sequence (evolutionary and pharmacological implications). Eur J Biochem 1983; 137: 545–51
- Pruzanski W, Vadas P, Stefanski E, Urowitz M B. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. J Rheumatol 1985; 12: 211–16
- Minami T, Tojo H, Shinomura Y, Tarui S, Okamoto M. Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut 1992; 33: 914–21
- Verheij H M, Westerman J, Sternby B, De Haas G H. The complete primary structure of phospholipase A2 from human pancreas. Biochim Biophys Acta 1983; 747: 93–9
- Tojo H, Ono T, Kuramitsu S, Kagamiyama H, Okamoto M. A phospholipase A2 in the supernatant fraction of rat spleen. J Biol Chem 1988; 263: 5724–31
- Sakata T, Nakamura E, Tsuruta Y. Presence of pancreatictype phospholipase A2 mRNA in rat gastric mucosa and lung. Biochim Biophys Acta 1989; 1007: 124–6
- Seilhamer J J, Randall T L, Yamanaka M, Johnson L K. Pancreatic phospholipase A2: isolation of the human gene and cDNAs from porcine pancreas and human lung. DNA 1986; 5: 519–27
- Kramer R M, Hession C, Johansen B. Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem 1989; 264: 5768–75
- Seilhamer J J, Randall T L, Johnson L K, Heinzmann C, Klisak I, Sparkes R S, Lusis A J. Novel gene exon homologous to pancreatic phospholipase A2: sequence and chromosomal mapping of both human genes. J Cellular Biochem 1989; 39: 327–37
- Grataroli R, Dijkman R, Dutilh C E, Van der Ouderaa F, De Haas G H. Studies on prophospholipase A2 and its enzyme from human pancreatic juice. Catalytic properties and sequence of the N-terminal region. Eur J Biochem 1982; 122: 111–17
- Gudgeon A M, Heath D I, Hurley P. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990; 335: 4–8
- Bowyer R C, Jehanli A, Patel G, Hermon-Taylor J. Development of enzyme-linked immuno-sorbent assay for free human procolipase activation peptide (APGPR). Clin Chim Acta 1991; 200: 137–52
- Rae D, Sumar N, Beechey-Newman N, Gudgeon M, Hermon-Taylor J. Type 1-prophospholipase A2 propeptide immunoreactivity is released from activated granulocytes. Clin Biochem 1995; 28: 71–8
- Clark M A, Chen M-J, Crooke S T, Bomalaski J S. Tumour necrosis factor (cachectin) induces phospholipase A2 activity and synthesis of a phospholipase A2-activating protein in endothelial cells. Biochem J 1988; 250: 125–32
- Rae D, Porter J, Beechey-Newman N, Sumar N, Bennett D, Hermon-Taylor J. Type 1-prophospholipase A2 propeptide in acute lung injury. Lancet 1995; 344: 1472–3
- Beechey-Newman N, Rae D, Sumar N, Hermon-Taylor J. Stratification of severity in acute pancreatitis by assay of trypsinogen and 1-prophospholipase A2. Activation peptides. Gastroenterology 1995; 108: A343